← Open Payments lookup

DEEP PATEL: Open Payments

NPI 1194247072 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,140 in 102 payments from 14 companies in 2025. Trend: 2023 $1,515 · 2024 $1,912 · 2025 $2,140

Food & beverage: $2,017Education: $123
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.29$587
E.R. Squibb & Sons, L.L.C.18$363
Teva Pharmaceuticals USA, Inc.16$311
Vanda Pharmaceuticals Inc.8$221
Otsuka America Pharmaceutical, Inc.10$214
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$106
Janssen Pharmaceuticals, Inc4$105
Lundbeck LLC4$86
ABBVIE INC.2$37
Supernus Pharmaceuticals, Inc.2$35

Products named: INGREZZA, COBENFY, REXULTI, FANAPT, UZEDY, CAPLYTA, SPRAVATO, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.